Shaun G. Goodman

Also affiliated with University of Toronto

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 28 papers. Top paper: “Effect of Genotype-Guided Oral P2Y12 Inhibitor Selection vs Conventional Clopidogrel Therapy on Ischemic Outcomes After Percutaneous Coronary Intervention”.

Effect of Genotype-Guided Oral P2Y12 Inhibitor Selection vs Conventional Clopidogrel Therapy on Ischemic Outcomes After Percutaneous Coronary Intervention

JAMA(2020)10.1001/jama.2020.12443

N/A

5.7DataRank · unranked

410 citations

Michael E. Farkouh, Derek So, Ryan J. Lennon, Nancy L. Geller, Verghese Mathew +22 more

Effect of High-Dose Trivalent vs Standard-Dose Quadrivalent Influenza Vaccine on Mortality or Cardiopulmonary Hospitalization in Patients With High-risk Cardiovascular Disease

JAMA(2020)10.1001/jama.2020.23649

N/A

3.7DataRank · unranked

130 citations

KyungMann Kim, Jacob A. Udell, Jacob Joseph, Akshay S. Desai, Michael E. Farkouh +22 more

Survival After Invasive or Conservative Management of Stable Coronary Disease

Circulation(2022)10.1161/circulationaha.122.062714

N/A

3.4DataRank · unranked

148 citations

Rebecca Anthopolos, Harmony R. Reynolds, Sripal Bangalore, Yifan Xu, Sean M. O’Brien +73 more

IL-6 inhibition with clazakizumab in patients receiving maintenance dialysis: a randomized phase 2b trial

Nature Medicine(2024)10.1038/s41591-024-03043-1

N/A

1.7DataRank · unranked

79 citations

Anna Marie Chang, G. Michael Felker, Mark Heise, Elena Velkoska, Bengt Fellström +18 more

Impact of Complete Revascularization in the ISCHEMIA Trial

Journal of the American College of Cardiology(2023)10.1016/j.jacc.2023.06.015

N/A

1.6DataRank · unranked

45 citations

Ziad A. Ali, Sean M. O’Brien, Grace L. Rhodes, Philippe Généreux, Sripal Bangalore +89 more

Long‐Term Efficacy, Safety, and Tolerability of Alirocumab in 8242 Patients Eligible for 3 to 5 Years of Placebo‐Controlled Observation in the ODYSSEY OUTCOMES Trial

Journal of the American Heart Association(2023)10.1161/jaha.122.029216

N/A

1.1DataRank · unranked

40 citations

Philippe Gabríel Steg, Yann Poulouin, Deepak L. Bhatt, Vera Bittner, Rafael Díaz +10 more

ABCD‐GENE Score and Clinical Outcomes Following Percutaneous Coronary Intervention: Insights from the TAILOR‐PCI Trial

Journal of the American Heart Association(2022)10.1161/jaha.121.024156

N/A

0.939DataRank · unranked

35 citations

Dominick J. Angiolillo, Ryan J. Lennon, Shaun G. Goodman, Sang‐Wook Kim, Fearghas O’Cochlain +6 more

Complete Revascularization and Angina-Related Health Status in the ISCHEMIA Trial

Journal of the American College of Cardiology(2023)10.1016/j.jacc.2023.05.025

N/A

0.855DataRank · unranked

25 citations

Philip G. Jones, Ziad A. Ali, Gregg W. Stone, Grace M. Rhodes, Sripal Bangalore +17 more

Achievement of ESC/EAS LDL-C treatment goals after an acute coronary syndrome with statin and alirocumab

European Journal of Preventive Cardiology(2022)10.1093/eurjpc/zwac107

N/A

0.846DataRank · unranked

15 citations

Jennifer McGinniss, Philippe Gabríel Steg, Deepak L. Bhatt, Vera Bittner, Rafael Díaz +12 more

Cause-Specific Mortality in Patients With Advanced Chronic Kidney Disease in the ISCHEMIA-CKD Trial

JACC: Cardiovascular Interventions(2023)10.1016/j.jcin.2022.10.062

N/A

0.689DataRank · unranked

18 citations

Karen P. Alexander, Zhen Huang, Roy O. Mathew, Jonathan Newman, Sean M. O’Brien +22 more

Restrictive Versus Liberal Transfusion in Patients With Type 1 or Type 2 Myocardial Infarction: A Prespecified Analysis of the MINT Trial

Circulation(2024)10.1161/circulationaha.124.071208

N/A

0.589DataRank · unranked

21 citations

J. Dawn Abbott, Brandon M. Herbert, Marnie Bertolet, Bernard Chaitman, Harvey D. White +19 more

Atrial fibrillation and clinical outcomes 1 to 3 years after myocardial infarction

Open Heart(2021)10.1136/openhrt-2021-001726

N/A

0.511DataRank · unranked

7 citations

Ruth Owen, Stuart Pocock, David Brieger, Satoshi Yasuda, José Carlos Nicolau +8 more

Safety of the PCSK9 inhibitor alirocumab: insights from 47 296 patient-years of observation

European Heart Journal - Cardiovascular Pharmacotherapy(2024)10.1093/ehjcvp/pvae025

N/A

0.483DataRank · unranked

24 citations

Philippe Gabríel Steg, Michael Szarek, Deepak L. Bhatt, Vera Bittner, Rafael Díaz +82 more

Association between levosimendan, postoperative AKI, and mortality in cardiac surgery: Insights from the LEVO-CTS trial

American Heart Journal(2020)10.1016/j.ahj.2020.10.066

N/A

0.449DataRank · unranked

19 citations

Amanda Stebbins, Vignesh Raman, Brooke Alhanti, Sean van Diepen, Matthias Heringlake +9 more

Effect of Alirocumab on Incidence of Atrial Fibrillation After Acute Coronary Syndromes: Insights from the ODYSSEY OUTCOMES Trial

The American Journal of Medicine(2022)10.1016/j.amjmed.2022.02.016

N/A

0.401DataRank · unranked

5 citations

Patrícia O. Guimarães, Gregory G. Schwartz, Deepak L. Bhatt, Vera Bittner, Andrzej Budaj +13 more

Risk of Incident Diabetes Related to Lipoprotein(a), LDL Cholesterol, and Their Changes With Alirocumab: Post Hoc Analyses of the ODYSSEY OUTCOMES Randomized Trial

Diabetes Care(2025)10.2337/dc24-2110

N/A

0.360DataRank · unranked

10 citations

Michael Szarek, J. Wouter Jukema, Christa M. Cobbaert, Esther Reijnders, Vera Bittner +9 more

Improving the Design of Future PCI Trials for Stable Coronary Artery Disease

Journal of the American College of Cardiology(2020)10.1016/j.jacc.2020.05.060

N/A

0.345DataRank · unranked

9 citations

David J. Moliterno, Dárrel P. Francis, Peter Jüni, Yves Rosenberg, Bimmer E. Claessen +8 more

Individualized transfusion decisions to minimize adverse cardiovascular outcomes in patients with acute myocardial infarction and anemia

American Heart Journal(2025)10.1016/j.ahj.2025.01.009

N/A

0.259DataRank · unranked

4 citations

Grégory Ducrocq, Marnie Bertolet, John H. Alexander, Shaun G. Goodman, Simone A. Glynn +14 more

Safety and Efficacy of CYP2C19 Genotype-Guided Escalation of P2Y12 Inhibitor Therapy After Percutaneous Coronary Intervention in Chronic Kidney Disease: a Post Hoc Analysis of the TAILOR-PCI Study

Cardiovascular Drugs and Therapy(2022)10.1007/s10557-022-07392-2

N/A

0.240DataRank · unranked

3 citations

Mandeep S. Sidhu, Charanjit S. Rihal, Ryan J. Lennon, Mohammed El‐Hajjar, Neil Yager +15 more

International Variation in Health Status Benefits in Patients Undergoing Initial Invasive Versus Conservative Management for Chronic Coronary Disease: Insights From the ISCHEMIA Trial

Circulation Cardiovascular Quality and Outcomes(2024)10.1161/circoutcomes.123.010534

N/A

0.208DataRank · unranked

3 citations

John A. Spertus, Dan Nguyen, Zhuxuan Fu, Philip G. Jones, Harmony R. Reynolds +18 more

Digital Tool-Assisted Hospitalization Detection in the Tailored Antiplatelet Initiation to Lessen Outcomes due to Decreased Clopidogrel Response After Percutaneous Coronary Intervention Study Compared to Traditional Site-Coordinator Ascertainment: Intervention Study

Journal of Medical Internet Research(2023)10.2196/47475

N/A

0.207DataRank · unranked

2 citations

Julia Byrne, Derek So, Erin Iturriaga, Ryan J. Lennon, Vishakantha Murthy +21 more

Pharmacologic and Genetic Downregulation of Proprotein Convertase Subtilisin/Kexin Type 9 and Survival From Sepsis

Critical Care Explorations(2023)10.1097/cce.0000000000000997

N/A

0.104DataRank · unranked

1 citations

Garen Manvelian, Alida Coppi, Amy Damask, Michael Cantor, Manuel A. R. Ferreira +35 more

Empagliflozin After Myocardial Infarction with or without diabetes and chronic kidney disease: Insights from EMPACT-MI

ESC Heart Failure(2025)10.1002/ehf2.15393

N/A

0DataRank · unranked

1 citations

Javed Butler, Jacob A. Udell, W. Schuyler Jones, Mark C. Petrie, Josephine Harrington +19 more

Predicting major adverse limb events in individuals with type 2 diabetes: Insights from the EXSCEL trial

Diabetic Medicine(2021)10.1111/dme.14552

N/A

0DataRank · unranked

8 citations

Robert M. Clare, Yuliya Lokhnygina, John B. Buse, Shaun G. Goodman, Brian G. Katona +9 more

Efficacy and Safety of Antithrombotic Therapy in Patients With Atrial Fibrillation, Recent Acute Coronary Syndrome, or Percutaneous Coronary Intervention and a History of Heart Failure: Insights From the AUGUSTUS Trial

Journal of the American Heart Association(2021)10.1161/jaha.121.023143

N/A

0DataRank · unranked

1 citations

Daniel M. Wojdyla, John H. Alexander, Shaun G. Goodman, Roxana Mehran, Stephan Windecker +7 more

Rationale and design of the TAILOR-PCI digital study: Transitioning a randomized controlled trial to a digital registry

American Heart Journal(2020)10.1016/j.ahj.2020.10.069

N/A

0DataRank · unranked

14 citations

Robert Avram, Derek So, Erin Iturriaga, Julia Byrne, Ryan J. Lennon +11 more

Effect of Reconstituted Human Apolipoprotein A-I on Recurrent Ischemic Events in Survivors of Acute MI

Journal of the American College of Cardiology(2024)10.1016/j.jacc.2024.03.396

N/A

0DataRank · unranked

30 citations

Serge Korjian, M. Cecilia Bahit, Gerald Chi, Danielle Duffy, John H. Alexander +34 more

Effect of CYP2C19 Genotype on Ischemic Outcomes During Oral P2Y12 Inhibitor Therapy

JACC: Cardiovascular Interventions(2021)10.1016/j.jcin.2021.01.024

N/A

0DataRank · unranked

165 citations

Charanjit S. Rihal, Ryan J. Lennon, Gil Marcus, Sanskriti Shrivastava, Malcolm R. Bell +10 more